A PHP Error was encountered

Severity: Warning

Message: date_default_timezone_get(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone.

Filename: libraries/Core.php

Line Number: 295

Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval... | NNDC
 

Neuralstem’s NSI-189 Trial in Major Depressive Disorder Receives FDA Approval…

Features Maurizio Fava, MD, Massachusetts General Hospital

ROCKVILLE, Md., Dec. 27, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been approved by the Food and Drug Administration to advance to Phase Ib in its ongoing clinical trial to test its novel neuroregenerative compound, NSI-189, for the treatment of major depressive disorder (MDD). Phase Ib will test the safety and tolerability of the drug in depressed patients. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in MDD as well as other diseases and conditions, such as Alzheimer's disease and post-traumatic stress disorder (PTSD).

Read the full article here

 

Posted to Archived News on January 20, 2012